ストックスクリーナーアプリを入手
29.10
2.28%
-0.68
前日終値:
$29.78
開ける：
$29.8
24時間の取引高:
469.15K
Relative Volume:
0.53
時価総額：
$1.76B
収益：
$13.05M
当期純損益:
$-60.54M
株価収益率:
-25.09
EPS:
-1.16
ネットキャッシュフロー:
$-37.82M
1週間 パフォーマンス:
-2.81%
1か月 パフォーマンス:
-9.09%
6か月 パフォーマンス:
-37.08%
1年 パフォーマンス:
-22.71%
1日の値動き範囲:
$28.91
$30.07
1週間の範囲:
$28.91
$32.00
52週間の値動き範囲:
$28.91
$71.71
Janux Therapeutics Inc Stock (JANX) Company Profile
名前
Janux Therapeutics Inc
セクター
電話
(858) 751-4493
住所
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
JANX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JANX
Janux Therapeutics Inc
|
29.10 | 1.76B | 13.05M | -60.54M | -37.82M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-03 | 繰り返されました | BTIG Research | Buy |
| 2024-12-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-11-22 | 開始されました | Leerink Partners | Outperform |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-09-06 | 開始されました | Stifel | Buy |
| 2024-05-30 | 開始されました | Scotiabank | Sector Perform |
| 2024-03-21 | 開始されました | BTIG Research | Buy |
| 2024-03-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-04-06 | 開始されました | Wedbush | Outperform |
| 2022-11-14 | 開始されました | William Blair | Outperform |
すべてを表示
Janux Therapeutics Inc (JANX) 最新ニュース
Janux Therapeutics stock hits 52-week low at $28.92 By Investing.com - Investing.com South Africa
Janux Therapeutics stock hits 52-week low at $28.92 - Investing.com India
Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts? - Yahoo Finance
Is Janux Therapeutics, Inc. (NASDAQ:JANX) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey
Janux Therapeutics, Inc. (JANX): Among Stocks Receiving the Most Insider Love in March - MSN
We're Interested To See How Janux Therapeutics (NASDAQ:JANX) Uses Its Cash Hoard To Grow - Yahoo Finance
12 Best Up and Coming Stocks to Buy According to Wall Street Analysts - Insider Monkey
First Week of JANX November 21st Options Trading - Nasdaq
RA Capital Management, L.P. Increases Stake in Janux Therapeutics Inc - GuruFocus.com
Insiders Are Spending Big: 15 Stocks Leading in March - Insider Monkey
Is Janux Therapeutics (JANX) a Worst High-Risk High-Reward Growth Stock to Buy? - Insider Monkey
10 Worst High-Risk High-Reward Growth Stocks To Buy - Insider Monkey
Commit To Buy Janux Therapeutics At $25, Earn 30% Annualized Using Options - Nasdaq
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
EGFR Non-Small Cell Lung Cancer Clinical and Non-Clinical - openPR
Janux Therapeutics (NASDAQ:JANX) Shares Gap Up Following Insider Buying Activity - Defense World
Insiders Are Loading Up on These 4 Biotech Stocks Now - 24/7 Wall St.
(JANX) Proactive Strategies - Stock Traders Daily
JANX stock touches 52-week low at $29.62 amid market shifts By Investing.com - Investing.com South Africa
JANX stock touches 52-week low at $29.62 amid market shifts - Investing.com India
Sunday Insider Moves: Top Buys and Sells from Friday’s Disclosures By Investing.com - Investing.com Australia
Sunday Insider Moves: Top Buys and Sells from Friday’s Disclosures - Investing.com India
Ra Capital Management, L.P. Purchases 341,742 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock - Defense World
Ra Capital Management, L.P. Purchases 110,206 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock - Defense World
Major Investment Alert: Janux Therapeutics Stock Sees Massive Buy-In! - TipRanks
Proficio Capital Partners LLC Invests $1.35 Million in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Ra capital management buys $25.3 million in Janux therapeutics stock By Investing.com - Investing.com Australia
Ra capital management buys $25.3 million in Janux therapeutics stock - Investing.com
HC Wainwright Has Pessimistic Outlook of JANX Q1 Earnings - Defense World
Janux Therapeutics (JANX) Projected to Post Quarterly Earnings on Friday - Defense World
Janux Therapeutics chief business officer sells shares for $107,174 By Investing.com - Investing.com South Africa
Janux Therapeutics, Inc. (NASDAQ:JANX) Given Consensus Rating of “Buy” by Brokerages - Defense World
Janux Therapeutics chief business officer sells shares for $107,174 - Investing.com India
Janux Therapeutics, Inc. (JANX): Among The Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey
JANUX THERAPEUTICS Earnings Preview: Recent $JANX Insider Trading, Hedge Fund Activity, and More - Nasdaq
10 Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Rhumbline Advisers - Defense World
Janux Therapeutics, Inc. (NASDAQ:JANX) Stock Holdings Lifted by New York State Common Retirement Fund - Defense World
Janux Therapeutics (NASDAQ:JANX) Given “Buy” Rating at HC Wainwright - Defense World
Janux Therapeutics (NASDAQ:JANX) Sets New 52-Week Low on Analyst Downgrade - Defense World
Promising Developments and Strong Financial Position Support Buy Rating for Janux Therapeutics - TipRanks
Janux Therapeutics’ (JANX) Outperform Rating Reiterated at Wedbush - Defense World
Positive Outlook for Janux Therapeutics Inc. Driven by Unique Therapeutic Potential and Strategic Advantages - TipRanks
Janux Therapeutics price target lowered to $41 from $62 at Scotiabank - Yahoo Finance
Janux Therapeutics Reports Strong Financial Position and Clinical Progress - TipRanks
Janux Therapeutics (NASDAQ:JANX) Announces Quarterly Earnings Results, Beats Estimates By $0.13 EPS - MarketBeat
Analyst Recommends ‘Buy’ for Janux Therapeutics Inc. Amid Share Price Decline and Promising Clinical Outlook - TipRanks
Janux Therapeutics Inc (JANX) 財務データ
収益
当期純利益
現金流量
EPS
Janux Therapeutics Inc (JANX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
Mar 05 '25 |
Buy |
30.64 |
341,742 |
10,471,352 |
9,658,988 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Mar 07 '25 |
Buy |
31.02 |
110,206 |
3,418,590 |
10,141,287 |
| Meyer Andrew Hollman | Chief Business Officer |
Mar 03 '25 |
Option Exercise |
4.21 |
3,334 |
14,036 |
85,473 |
| Meyer Andrew Hollman | Chief Business Officer |
Mar 03 '25 |
Sale |
32.15 |
3,334 |
107,174 |
82,139 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):